- Original Articles
- Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea
-
Hui Xing Tan, Desmond Chun Hwee Teo, Dongyun Lee, Chungsoo Kim, Jing Wei Neo, Cynthia Sung, Haroun Chahed, Pei San Ang, Doreen Su Yin Tan, Rae Woong Park, Sreemanee Raaj Dorajoo
-
Healthc Inform Res. 2022;28(2):112-122. Published online April 30, 2022
-
-
Full text PubReader ePub Crossref - TDM PDF Supplementary Material
- Toolkit to Compute Time-Based Elixhauser Comorbidity Indices and Extension to Common Data Models
-
Shorabuddin Syed, Ahmad Baghal, Fred Prior, Meredith Zozus, Shaymaa Al-Shukri, Hafsa Bareen Syeda, Maryam Garza, Salma Begum, Kim Gates, Mahanazuddin Syed, Kevin W. Sexton
-
Healthc Inform Res. 2020;26(3):193-200. Published online July 31, 2020
-
-
Full text PubReader ePub Crossref - TDM PDF Supplementary Material